GTX
GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.
GTX
Industry:
Biopharma Biotechnology Health Care
Founded:
1997-01-01
Address:
Memphis, Tennessee, United States
Country:
United States
Website Url:
http://www.gtxinc.com
Total Employee:
51+
Status:
Active
Contact:
9012718733
Email Addresses:
[email protected]
Total Funding:
163.18 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Domain Not Resolving Mobile Non Scaleable Content Sitelinks Search Box Organization Schema
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Aisling Capital
Aisling Capital investment in Post-IPO Equity - GTx
Abingworth
Abingworth investment in Post-IPO Equity - GTx
CAM Capital
CAM Capital investment in Post-IPO Equity - GTx
Boxer Capital
Boxer Capital investment in Post-IPO Equity - GTx
Amzak Capital Management
Amzak Capital Management investment in Post-IPO Equity - GTx
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - GTx
MB Venture Partners
MB Venture Partners investment in Series E - GTx
Joseph R. Hyde III
Joseph R. Hyde III investment in Series E - GTx
Oracle
Oracle investment in Series E - GTx
Key Employee Changes
Date | New article |
---|---|
2021-02-22 | GTX appoints Alex Thibault as Chief Operating Officer Français |
Official Site Inspections
http://www.gtxinc.com Semrush global rank: 8.99 M Semrush visits lastest month: 227
- Host name: 172.67.147.1
- IP address: 172.67.147.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "GTx"
GTx - Crunchbase Company Profile & Funding
GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways. GTx merged with Oncternal Therapeutics on …See details»
GTx Incorporated - Wikipedia
GTx, Inc. was a pharmaceutical company working on drugs in the selective estrogen receptor modulator (SERM) and selective androgen receptor modulator (SARM) classes. Its drugs in …See details»
GTX Inc
Jul 19, 2022 · News and latest news about biotechnology in the pharmaceutical industry and medicine. Explore through this interesting article, the authentic and new world of medical technology, its definition and its current developments. …See details»
GTx (Pharmaceuticals) - PitchBook
GTx Inc is a biopharmaceutical company. It is involved in the business of discovery, development, and commercialization of small molecules for the treatment of cancer including treatment of breast and prostate cancer and …See details»
GTx Company Profile - Office Locations, Competitors, Financials
GTx is a pharmaceutical company and developer of drugs that utilize hormonal pathways. It focuses on androgen receptor modulators, also referred to as SARMs, to treat a number of …See details»
GTx, Inc.: Contact Details and Business Profile - RocketReach
GTx, Inc. is a Biotechnology, Drug Manufacturing & Research, and Biopharma company_reader located in Memphis, Tennessee with $641000 in revenue and 66 employees. Find top …See details»
GTx, Inc. - Company Profile & Staff Directory | ContactOut
GTx, Inc., headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of …See details»
About: GTx Incorporated - DBpedia Association
An Entity of Type: Public company, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org GTx, Inc. is a pharmaceutical company that is working on drugs in the selective …See details»
Oncternal Therapeutics Completes Reverse Merger with GTx, Inc.
SAN DIEGO, June 10, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., (Nasdaq: ONCT) a clinical-stage biotechnology company developing potential first-in-class product …See details»
GTx, Inc - Overview and Employees Official Email & Contacts
Explore all about GTx, Inc and get an overview of the company, employee designation, official emails and contacts, and similar players in this industry.See details»
Articles about GTx, Inc. - BioSpace
GTx, Inc. today reported financial results for the third quarter ended September 30, 2018, and provided a corporate update.See details»
GTx, Inc. to Present at the SG Cowen 5th Annual Global Healthcare ...
Memphis, Tenn.—November 15, 2004 - GTx, Inc. (Nasdaq: GTXI), a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics for serious …See details»
GTx, Inc. to Present at the BioCentury Future Leaders in the …
Mar 31, 2005 · GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics primarily related to the treatment of serious men's health …See details»
GTx, Inc. (GTXI) and Oncternal Therapeutics Enter into Definitive ...
Mar 7, 2019 · GTx, Inc. (Nasdaq: GTXI) and Oncternal Therapeutics, Inc., a privately held clinical-stage biotechnology company developing potential first-in-class therapeutic candidates for …See details»
GTx, Inc. - Cruelty Free Investing
GTx, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for …See details»
GTx, Inc. Stock Nasdaq - MarketScreener.com
GTx, Inc. (ZB_59660033.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock GTx, Inc. | Nasdaq: | NasdaqSee details»
GTx, Inc. and Merck & Co., Inc. in Drug Venture to Treat Age
Nov 6, 2007 · GTx, headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively …See details»
GTx, Inc. to Participate in the Baird 2018 Global Healthcare …
Aug 30, 2018 · GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious …See details»
GTx, Inc. (GTx, Inc.) - 药物管线_专利_临床试验_投融营收
GTx-024 is an orally bioavailable and tissue-selective nonsteroidal selective androgen receptor modulator (SARM) that has demonstrated androgenic and anabolic activity and is currently …See details»
GTx Inc. to merge with Oncternal Therapeutics, end Memphis …
Memphis-based biopharmaceutical company GTx Inc. and a San Diego-based biotech firm are planning a reverse merger that will end GTx’s Memphis operations.See details»